Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Rationale and Design of the DIPAK 1 Study: A Randomized Controlled Clinical Trial Assessing the Efficacy of Lanreotide to Halt Disease Progression in Autosomal Dominant Polycystic Kidney Disease
PaperCitations, authors & open-access status
Rationale and Design of the DIPAK 1 Study: A Randomized Controlled Clinical Trial Assessing the Efficacy of Lanreotide to Halt Disease Progression in Autosomal Dominant Polycystic Kidney Disease is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 70 citations, 2013 year and green oa status.
70
Citations
2013
Year
green
OA Status